Use of a panel of markers such as GATA3 and CD10 and awareness of the lack of specificity of PAX2 will help avoid misdiagnosis, particularly when MLA and other uterine carcinomas showing mesonephric-like differentiation are suspected. The gene discussed is MME; the disease is uterine carcinoma.